Non-pneumonic airway infections: When and why are antibiotics indicated?;Wann und warum sind bei Infekten der Atemwege (Pneumonie ausgenommen) Antibiotika indiziert?

Praxis

Volumn 86, Issue 18, 1997, Pages 737-740

  Brandli O ^a   Luterbacher, T ^a   Egli, N ^a  

^a Zürcher Höhenklinik Wald ^*  (Switzerland)

Author keywords

antibiotic resistance; antibiotic therapy; chronic bronchitis; over the counter medication; respiratory tract infections

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; AZITHROMYCIN; CEPHALOSPORIN; CLARITHROMYCIN; COTRIMOXAZOLE; MACROLIDE; PENICILLIN DERIVATIVE;

ADULT; AGE; BRONCHITIS; CHILD; DOCTOR PATIENT RELATION; DRUG COST; EPIGLOTTITIS; HUMAN; LARYNGITIS; OTITIS; PRESCRIPTION; QUALITY OF LIFE; RESPIRATORY TRACT INFECTION; REVIEW; RHINITIS; SELF MEDICATION; SINUSITIS; TONSILLITIS;

ADULT; AGED; ANTI-BACTERIAL AGENTS; DRUG COSTS; DRUG HYPERSENSITIVITY; FAMILY PRACTICE; HUMANS; INFANT; PHYSICIAN-PATIENT RELATIONS; RESPIRATORY TRACT INFECTIONS; RISK FACTORS;

EID: 0031001435     PISSN: 16618157     EISSN: 16618165     Source Type: Journal    
DOI: None     Document Type: Review

References (14)

1. Gadomski A. M.: Potential interventions for preventing pneumonia among young children: lack of effect of antibiotic treatment for upper respiratory infections. Pediatr Infect Dis J 1993; 12: 115-20.
2. Huchon G. J. et al.: Initial antibiotic therapy for lower respiratory tract infection in the community: a European survey. Eur Respir J 1996; 9: 1590-5.
3. Arason V. A et al.: Do antimicrobials increase the carriage rate of penicillin resistant pneumococci in children? Cross sectional prevalence study. BMJ 1996; 313: 387-391.
4. Kaiser L. et al.: Effects of antibiotic treatment in the subset of common-cold patients who have bacteria in nasopharyngeal secretions. Lancet 1996; 347: 1507-1510.
5. Wiist J., Kayser F. H.: Die Empfindlichkeit von Bakterien gegen Chemotherapeutika (Zürich. 1993). Schw. Rundsch. f. Medizin (PRAXIS) 1995; 84 (4): 98-105.
6. Lindbäck S. et al.: The value of C-reactive protein as a marker of bacterial infection in patients with septicaemia/endocarditis and influenza. Scand J Infect Dis 1992; 21: 543-9.
7. Smith M. B. H., Feldman W.: Over-the-counter cold medications. A critical review of clinical trials between 1950 and 1991. JAMA 1993; 269: 2258-63.
8. Saint S., Bent S., Vittinghoff E., Grady D.: Antibiotics in chronic obstructive pulmonary disease exacerbations. A Meta analysis. JAMA 1995; 273: 857-860.
9. Macfarlane J. T., Colville A., Guion A., Macfarlane R. M., Rose D. H.: Prospective study of aetiology and outcome of adult lower-respiratorytract infections in the community. Lancet 1993; 341: 511-514.
10. Nichol KL et al.: The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. NEJM 1994; 331 (12): 778-784.
11. Marrie T. J.: Chlamydia pneumoniae. Thorax 1993; 48: 1-4.
12. Jenkinson D.: Natural course of 500 consecutive cases of whooping cough: a general practice population study. BMJ 1995: 310: 299-302.
13. Nicholson K. G. et al.: Risk factors for lower respiriatory complications of rhinovirus infections in elderly people living in the community: prospective cohort study. BMJ 1996; 313: 1119-23.
14. Brändli O.: Sind inhalierte Staubpartikel schädlich für unsere Lungen? SMW 1996; 126: 2165-2174.